125 related articles for article (PubMed ID: 6436288)
1. Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas.
Snyder PJ; Bashey HM; Kim SU; Chappel SC
J Clin Endocrinol Metab; 1984 Dec; 59(6):1169-75. PubMed ID: 6436288
[TBL] [Abstract][Full Text] [Related]
2. Gonadotroph cell adenomas of the pituitary.
Snyder PJ
Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
[TBL] [Abstract][Full Text] [Related]
3. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone.
Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
J Clin Endocrinol Metab; 1993 Nov; 77(5):1352-5. PubMed ID: 8077332
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture.
Snyder PJ; Bashey HM; Phillips JL; Gennarelli TA
J Clin Endocrinol Metab; 1985 Dec; 61(6):1061-5. PubMed ID: 2414310
[TBL] [Abstract][Full Text] [Related]
5. Recognition of gonadotroph adenomas in women.
Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
Kwekkeboom DJ; de Jong FH; Lamberts SW
J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356
[TBL] [Abstract][Full Text] [Related]
7. Gonadotroph cell pituitary adenomas.
Snyder PJ
Endocrinol Metab Clin North Am; 1987 Sep; 16(3):755-64. PubMed ID: 3319601
[TBL] [Abstract][Full Text] [Related]
8. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
9. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion.
Snyder PJ; Muzyka R; Johnson J; Utiger RD
J Clin Endocrinol Metab; 1980 Oct; 51(4):744-8. PubMed ID: 6774992
[TBL] [Abstract][Full Text] [Related]
11. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
[TBL] [Abstract][Full Text] [Related]
12. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.
Popovic V; Damjanovic S
Thyroid; 1998 Oct; 8(10):935-9. PubMed ID: 9827662
[TBL] [Abstract][Full Text] [Related]
13. Follicle-stimulating hormone-secreting pituitary tumor with concomitant elevation of serum alpha-subunit levels.
Borges JL; Ridgway EC; Kovacs K; Rogol AD; Thorner MO
J Clin Endocrinol Metab; 1984 May; 58(5):937-41. PubMed ID: 6200493
[TBL] [Abstract][Full Text] [Related]
14. Structure-function correlations of human pituitary gonadotroph adenomas in vitro.
Asa SL; Gerrie BM; Kovacs K; Horvath E; Singer W; Killinger DW; Smyth HS
Lab Invest; 1988 Apr; 58(4):403-10. PubMed ID: 2451766
[TBL] [Abstract][Full Text] [Related]
15. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.
Harris RI; Schatz NJ; Gennarelli T; Savino PJ; Cobbs WH; Snyder PJ
J Clin Endocrinol Metab; 1983 Jun; 56(6):1288-93. PubMed ID: 6404924
[TBL] [Abstract][Full Text] [Related]
16. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.
Daneshdoost L; Pavlou SN; Molitch ME; Gennarelli TA; Savino PJ; Sergott RC; Bosley TM; River JE; Vale WW; Snyder PJ
J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048
[TBL] [Abstract][Full Text] [Related]
18. Hypersecretion of LH and FSH by a pituitary adenoma.
Snyder PJ; Sterling FH
J Clin Endocrinol Metab; 1976 Mar; 42(3):544-50. PubMed ID: 767353
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
Sassolas G; Lejeune H; Trouillas J; Forest MG; Claustrat B; Lahlou N; Loras B
J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850
[TBL] [Abstract][Full Text] [Related]
20. Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone.
Galway AB; Hsueh AJ; Daneshdoost L; Zhou MH; Pavlou SN; Snyder PJ
J Clin Endocrinol Metab; 1990 Oct; 71(4):907-12. PubMed ID: 2119391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
